BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT

A recent approach for limiting production of pro-inflammatory cytokines has been to target bromodomain and extra-terminal (BET) proteins. These epigenetic readers of histone acetylation regulate transcription of genes involved in inflammation, cardiovascular disease, and cancer. Development of BET i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Immunol
Huvudupphovsmän: Copsel, Sabrina N., Lightbourn, Casey O., Barreras, Henry, Lohse, Ines, Wolf, Dietlinde, Bader, Cameron S., Manov, John, Kale, Brandon J., Shah, Devangi, Brothers, Shaun P., Perez, Victor L., Komanduri, Krishna V., Wahlestedt, Claes, Levy, Robert B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2019
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353853/
https://ncbi.nlm.nih.gov/pubmed/30733722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.03104
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk